UtahH.B. 2642026 General SessionHouseWALLET

Prescription Medication Amendments

Sponsored By: Raymond P. Ward (Republican)

Signed by Governor

Health and Human ServicesHealth CareHealth Care FacilitiesLabor and EmploymentHealth Care ProfessionalsDepartment of Health and Human ServicesPharmaciesPublic HealthPharmacistsPharmaceuticalsOccupational and Professional Licensing

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

Analyzed Economic Effects

5 provisions identified: 1 benefits, 1 costs, 3 mixed.

State list for similar drug swaps

Beginning May 6, 2026, the state creates a list of therapeutically similar drugs after consulting two medical boards. Either board can block adding a drug to the list. The state must first consider albuterol inhalers, injectable insulin, and diabetic test strips. Biological products now count as “drugs” under these substitution rules.

When pharmacies can swap your meds

Beginning May 6, 2026, a pharmacist may give you an FDA‑rated equivalent generic if you agree and your prescriber has not blocked it. For a therapeutically similar product, your prescriber must allow it, the drug must be on the state’s similar‑drug list, and you must consent. The swap must lower your cost, be on the same or a better formulary tier, be needed because the original is unavailable, or be agreed as helpful by you and the pharmacist. The pharmacist must counsel you, tell you about any swap, label the dispensed drug’s name, and record both the prescribed and dispensed names. Out‑of‑state mail pharmacies must also notify you by phone or in writing when they substitute. A prescriber can still write “dispense as written” (or say it by phone) to block any substitution, and brand‑name swaps without an FDA equivalent need prescriber approval.

Refill window and out-of-state prescriptions

Beginning May 6, 2026, a prescription cannot be dispensed after one year from when it started, unless another law allows it. If refills are allowed, you may refill up to two years from the original issue date. Utah pharmacies may fill or refill a valid prescription from another state after they verify it. Controlled substance rules still apply.

Tighter limits on state standing orders

Beginning May 6, 2026, the health department may issue a standing prescription only for a clear clinical use, an FDA‑approved diagnosis, and when it is clinically appropriate. This narrows when blanket standing orders can be used.

Safety and legal rules on substitutions

Beginning May 6, 2026, if you have a seizure disorder and your prescriber finds a swap unsafe, the prescriber must prohibit it. If a pharmacist cannot fill as written for seizure care, they must notify the prescriber before substituting, unless Medicaid pays for the substitute. A pharmacist who substitutes under the law has no greater liability than filling the original drug. A prescriber’s failure to say “no substitution” is not evidence of negligence.

Free Policy Watch

You just read the policy. Now see what it costs you.

Pick a topic. PRIA runs your household against live legislation and sends you a free personalized readout.

Pick a topic to get started

Sponsors & Cosponsors

Sponsor

  • Raymond P. Ward

    Republican • House

Cosponsors

  • Evan J. Vickers

    Republican • Senate

Roll Call Votes

All Roll Calls

Yes: 218 • No: 0

House vote 2/20/2026

House/ concurs with Senate amendment

Yes: 72 • No: 0

Senate vote 2/19/2026

Senate/ passed 3rd reading

Yes: 25 • No: 0

Senate vote 2/18/2026

Senate/ floor amendment

Yes: 0 • No: 0

Senate vote 2/18/2026

Senate/ passed 2nd reading

Yes: 24 • No: 0

House vote 2/12/2026

Senate Comm - Favorable Recommendation

Yes: 5 • No: 0

House vote 2/6/2026

House/ passed 3rd reading

Yes: 69 • No: 0

House vote 1/27/2026

House Comm - Favorable Recommendation

Yes: 12 • No: 0

House vote 1/27/2026

House Comm - Substitute Recommendation

Yes: 11 • No: 0

Actions Timeline

  1. Governor Signed

    3/17/2026
  2. House/ to Governor

    3/11/2026House
  3. House/ received enrolled bill from Printing

    3/11/2026House
  4. House/ enrolled bill to Printing

    3/5/2026House
  5. Enrolled Bill Returned to House or Senate

    3/5/2026
  6. Draft of Enrolled Bill Prepared

    2/25/2026
  7. Bill Received from House for Enrolling

    2/25/2026
  8. House/ signed by Speaker/ sent for enrolling

    2/20/2026House
  9. House/ received from Senate

    2/20/2026House
  10. Senate/ to House

    2/20/2026Senate
  11. Senate/ signed by President/ returned to House

    2/20/2026Senate
  12. Senate/ received from House

    2/20/2026Senate
  13. House/ to Senate

    2/20/2026House
  14. House/ concurs with Senate amendment

    2/20/2026House
  15. House/ placed on Concurrence Calendar

    2/19/2026House
  16. House/ received from Senate

    2/19/2026House
  17. Senate/ to House with amendments

    2/19/2026Senate
  18. Senate/ passed 3rd reading

    2/19/2026Senate
  19. Senate/ 3rd reading

    2/19/2026Senate
  20. Senate/ passed 2nd reading

    2/18/2026Senate
  21. Senate/ floor amendment

    2/18/2026Senate
  22. Senate/ 2nd reading

    2/18/2026Senate
  23. Senate/ placed on 2nd Reading Calendar

    2/17/2026Senate
  24. Senate/ committee report favorable

    2/17/2026Senate
  25. Senate Comm - Favorable Recommendation

    2/12/2026

Bill Text

  • Enrolled

    3/5/2026

  • Amended 2/18/2026 15:02:20

    2/18/2026

  • Substitute #1

    1/27/2026

  • Introduced

    1/15/2026

Related Bills

Back to State Legislation

Take It Personal

Get Your Personalized Policy View

Take the PRIA Score to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in